Treatment during pregnancy | Women with adverse outcomes, N (%) | Crude RR (95% CI) | Adjusted RR (95% CI) |
---|---|---|---|
Non-treponemal serum test titers ≤1:8 (N = 999) | |||
Treatment initiation | |||
Penicillin < 28w | 95 (10.6) | reference | reference |
Penicillin ≥28w | 25 (34.6) | 0.88 (0.59–1.33) | 0.91 (0.60–1.38)b |
No treatment | 63 (41.7) | 1.73 (1.31–2.28) | 1.77 (1.31–2.40)b |
Treatment course | |||
2 courses | 67 (14.9) | reference | reference |
1 course | 31 (16.2) | 1.09 (0.74–1.61) | 1.21 (0.82–1.81)c |
Insufficient treatment | 22 (16.9) | 1.14 (0.73–1.77) | 1.22 (0.78–1.91)c |
No treatment | 63 (27.6) | 1.86 (1.37–2.52) | – |
Non-treponemal serum test titers >1:8 (N = 170) | |||
Treatment initiation | |||
Penicillin <28w | 14 (15.9) | reference | reference |
Penicillin ≥28w | 10 (43.5) | 2.73 (1.40–5.34) | 2.34 (1.22–4.48)b |
No treatment | 34 (57.6) | 3.62 (2.14–6.14) | 2.93 (1.66–5.17)b |
Treatment course | |||
2 courses | 6 (14.7) | reference | reference |
1 course | 7 (31.3) | 3.39 (1.28–9.02) | 2.19 (0.90–5.31)c |
Insufficient treatment | 11 (50.0) | 4.69 (1.95–11.32) | 2.40 (1.05–5.52)c |
No treatment | 34 (63.4) | 6.15 (2.78–13.58) | – |